MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.

Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL. · 2019

Read MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. by Weng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6421700.txt.

Description

Weng and co-authors report a breast cancer study in Molecular Cancer. Triple-negative breast cancer has few treatment options and a poor outlook. The team traced a signal chain that helps it grow and spread.

A gene called MCT-1 acts as an on-switch in these tumors. It lowers miR-34a, which frees interleukin-6 signals to flow. That chain drives shape change, stem-like traits, and a tumor-friendly macrophage state. High MCT-1 marked poor outcomes in patients, they report. Blocking parts of the chain may aid this hard cancer, the authors argue.

Catalog record

CREATORWeng YS, Tseng HY, Chen YA, Shen PC, Al Haq AT, Chen LM, Tung YC, Hsu HL.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6421700

Browse the full library · About the Tower of Babel